GSK »

Fulcrum Therapeutics shares owned by GSK

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by GSK from 13F filings

Historical chart of GSK investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by GSK consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by GSK

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.5M 1.8M 3.66

More positions owned by GSK

Crispr Therapeutics Namen Akt (CRSP)
Wave Life Sciences SHS (WVE)
Vir Biotechnology (VIR)
Biontech Se Sponsored Ads (BNTX)
Ideaya Biosciences (IDYA)
Cytokinetics Com New (CYTK)
Lyell Immunopharma Com New (LYEL)
Spero Therapeutics (SPRO)
Nkarta (NKTX)
Fulcrum Therapeutics (FULC)
Bicycle Therapeutics Sponsored Ads (BCYC)
CVRX (CVRX)
Regenxbio Inc equity us cm (RGNX)

View all positions for GSK

Top funds holding Fulcrum Therapeutics

Suvretta Capital Management
RA Capital Management
BlackRock
TCG Crossover Management
Braidwell
Nantahala Capital Management
Vanguard Capital Management
Siren
First Turn Management
Balyasny Asset Management
Point72 Asset Management
GSK
Jones Hill Capital
Renaissance Technologies
D. E. Shaw & Co

View all funds holding Fulcrum Therapeutics